Skip to main content
SpringerLink
Log in

Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls

  • Esophageal, Gastric, And Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The objective of this study was to determine whether gastric secretion of acid and pepsin is different in the subset of esophagitis patients who also have Barrett's esophagus. Basal and stimulated gastric secretions were studied for 1 hr in the unstimulated state and 1 hr after pentagastrin 6 µg/kg subcutaneous injection. Because Barrett's patients are predominantly male, the 30 patients were matched with patients who had esophagitis, but not Barrett's, for sex (26 men, 4 women) and age as well as for background gastrointestinal disease (duodenal ulcer in 10, no ulcer disease in 17 and Zollinger-Ellison hypersecretors in 3). Patients with Barrett's weighed more than controls (P<0.05). Acid and pepsin output in the basal and stimulated state were no different in Barrett's and their appropriately matched controls. Overnight fasting residue—volume, pH, acid and pepsin concentrations, and bile content—were also alike. The severity of esophagitis or prevalence of esophageal ulcer or stricture was not different between those with and without Barrett's and in neither was the grade of esophagitis related to acid or pepsin output. It is concluded that Barrett's esophagus patients do not have gastric secretions different from appropriately matched controls with esophagitis alone. When present, esophagitis due to reflux in Barrett's epithelium should be treated on its merits by appropriate reduction of acid exposure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Spechler ST, Goyal RK: Barrett's esophagus. N Engl J Med 315:362–371, 1986

    Google Scholar 

  2. Cameron AJ, Lomboy CT: Barrett's esophagus: Age, prevalence, and extent of columnar epithelium. Gastroenterology 103:1241–1245, 1992

    Google Scholar 

  3. Robertson D, Aldersley M, Shepherd H, Smith CL: Patterns of acid reflux in complicated oesophagitis. Gut 28:1484–1488, 1987

    Google Scholar 

  4. Dent J, Bremner CG, Collen MJ, Haggitt RC, Spechler SJ: Working party report to the World Congresses of Gastroenterology, Sydney 1990. Barrett's oesophagus. J Gastroenterol Hepatol 6:1–22, 1991

    Google Scholar 

  5. Marks RD, Richter JE: Gastroesophageal reflux disease.In Peptic Ulcer Disease and Other Acid-Related Disorders. D Zakim, AI Dannenberg (eds). New York, Academic Research Associates, 1991

    Google Scholar 

  6. Dahms BB, Rothstein FC: Barrett's esophagus in children. A consequence of chronic gastroesophageal reflux. Gastroenterology 86:318–323, 1984

    Google Scholar 

  7. Bremner CG, Lynch VP, Ellis FH: Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 68:209–216, 1970

    Google Scholar 

  8. Haggitt RC: Barrett's esophagus: Definition and histology.In Accomplishments in Oncology. Premalignant Lesions of the Esophagus and Colon. BI Hirschowitz (ed). Philadelphia, JP Lippincott, 1989, pp 19–28

    Google Scholar 

  9. Gillen P, Keeling P, Byrne PJ, Hennessy TPJ: Barrett's esophagus: pH profile. Br J Surg 74:774–776, 1987

    Google Scholar 

  10. Collen MJ, Johnson DA: Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Dig Dis Sci 37:570–576, 1992

    Google Scholar 

  11. Collen MJ, Johnson DA, Sheridan MJ: Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Dig Dis Sci 39:410–417, 1994

    Google Scholar 

  12. Mulholland MW, Reid BJ, Levine DS, Rubin CE: Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci 34:1329–1335, 1989

    Google Scholar 

  13. Collen MJ, Strong RM: Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci 37:897–903, 1992

    Google Scholar 

  14. Brown CM, Rees DW: Review article: Factors protecting the esophagus against acid-mediated injury. Alimen Pharmacol Ther 9:251–262, 1995

    Google Scholar 

  15. Hirschowitz BI: A critical analysis, with appropriate controls of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149–1158, 1991

    Google Scholar 

  16. Attwood SEA, DeMeester TR, Bremner CG, Barlow AP, Hinder RA: Alkaline gastroesophageal reflux: Implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery 106:764–770, 1989

    Google Scholar 

  17. Gore CJ, Healey CJ, Sutton R, Eyre-Brook IA, Gear MWL, Shepherd NA, Wilkinson P: Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 7:623–628, 1993

    Google Scholar 

  18. Sampliner RE, Garewal HS, Fennerty MB, Aickin M: Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 35:93–96, 1990

    Google Scholar 

  19. Sampliner RE: Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 89:1844–1848, 1994

    Google Scholar 

  20. Williamson WA, Ellis FH, Gibb SP, Shahia DM, Avetz HT: Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg 49:537–542, 1990

    Google Scholar 

  21. Hetzel DJ, Dent J, Reed WD, Firoze NM, MacKinnon M, McCarthy JH, et al: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95:903–912, 1988

    Google Scholar 

  22. Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, et al: Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The US multicenter study. Gastroenterology 102:109–118, 1992

    Google Scholar 

  23. Klinkenberg-Knol EC, Festen HPM, Jansen BMJ, Lamers CBHW, Frits N, Snel P, et al: Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety. Ann Intern Med 121:161–167, 1994

    Google Scholar 

  24. Hirschowitz BI: Acid and pepsin secretion in patients with esophagitis refractory to treatment with H2 antagonists. Scand J Gastroenterol 27:449–452, 1992

    Google Scholar 

  25. Hirschowitz BI: Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer. Gastroenterology 86:843–851, 1984

    Google Scholar 

  26. Kirkpatrick PM Jr, Hirschowitz BI: Duodenal ulcer with unexplained marked basal gastric acid hypersecretion. Gastroenterology 79:4–10, 1980

    Google Scholar 

  27. Hirschowitz BI, Groarke J: Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controls. Dig Dis Sci 38:1874–1884, 1993

    Google Scholar 

  28. McClave SA, Boyce HW, Gottfried MR: Early diagnosis of columnar-lined esophagus: A new endoscopic diagnostic criterion. Gastrointest Endosc 33:413–416, 1987

    Google Scholar 

  29. Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske FF: Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 56:223–230, 1969

    Google Scholar 

  30. Hirschowitz BI: Pepsin in the pathogenesis of peptic ulceration.In Mechanisms of Peptic Ulcer Healing. F Halter, A Garner, GNJ Tytgat (eds). Proceedings of the 59th Falk Symposium at Freiburg-im-Breisgau, Germany, October 15–17, 1990. Dordrecht, The Netherlands, Kluwer Academic Publishers, 1990, pp 183–194

    Google Scholar 

  31. Gotley DC, Morgan AP, Ball D, Owen RW, Cooper MJ: Composition of gastroesophageal refluxate. Gut 32:1093–1099, 1991

    Google Scholar 

  32. Neumann CS, Cooper BT: 24 Hour ambulatory pH monitoring in uncomplicated Barrett's oesophagus. Gut 35:1352–1355, 1994

    Google Scholar 

  33. Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS: Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 38:365–368, 1993

    Google Scholar 

  34. Brand DL, Ylvisaker JF, Gelfand M, Pope CE: Regression of columnar lined esophageal (Barrett's) epithelium after surgery. N Engl J Med 302:844–848, 1980

    Google Scholar 

  35. Deviere J, Buset M, Dumonceau J-M, Rickaert F, Cremer M: Regression of Barrett's epithelium with omeprazole. N Engl J Med 320:1497–1498, 1989

    Google Scholar 

  36. Vaezi MF, Richter JE: Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 117:699–704, 1995

    Google Scholar 

  37. Katzka DA, Reynolds JC, Saul SH, Plotkin A, Lang CA, Ouyang A, Jimenez S, Cohen S: Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 82:46–52, 1987

    Google Scholar 

  38. Johns BAE: Developmental changes in the oesophageal epithelium in man. J Anat 86:431–442, 1952

    Google Scholar 

  39. Strader DB, Benjamin SB, Orbuch M, Lubensky TA, Gibril F, Weber C, Fishbeyn VA, Jensen RT, Metz DC: Esophageal function and occurrence of Barrett's esophagus to Zollinger-Ellison syndrome. Digestion 56:347–356, 1995

    Google Scholar 

  40. McDonald WC: Adenocarcinoma of the gastric cardia.In Accomplishments in Oncology. Premalignant Lesions of the Esophagus and Colon. BI Hirschowitz (ed). Philadelphia, JP Lippincott, 1989, pp 66–72

    Google Scholar 

  41. Reid BJ, Rabinovitch PS: Barrett's esophagus: A human model of genomic instability in neoplastic progression.In Accomplishments in Oncology. Premalignant Lesions of the Esophagus and Colon. BI Hirschowitz (ed). Philadelphia, JP Lippincott, 1989, pp 32–41

    Google Scholar 

  42. Fennerty MB, Sampliner RE, Garewal HS: Review article: Barrett's oesophagus—cancer risk, biology and therapeutic management. Aliment Pharmacol Ther 7:339–345, 1993

    Google Scholar 

  43. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR: Increasing incidence of adenocarcinoma of the esophagus and esophageal junction. Gastroenterology 104:510–513, 1993

    Google Scholar 

  44. Cameron AJ, Ott BJ, Payne WS: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313:857–859, 1985

    Google Scholar 

  45. Hamilton SR, Hutcheon DF, Ravich WJ, Cameron JL, Paulson M: Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux. Gastroenterology 86:356–360, 1984

    Google Scholar 

  46. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS: Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 104:1686–1691, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, University of Alabama at Birmingham, 35294, Birmingham, Alabama

    Basil I. Hirschowitz MD

Authors
  1. Basil I. Hirschowitz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirschowitz, B.I. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls. Digest Dis Sci 41, 1384–1391 (1996). https://doi.org/10.1007/BF02088563

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02088563

Key words

Search

Navigation